Case number 3:18-cv-13701
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. PAR PHARMACEUTICAL, INC. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 12, 2018 | 10 | Order of Dismissal (1) Docket Text: NOTICE and ORDER Voluntarily Dismissing Case without prejudice. Signed by Judge Peter G. Sheridan on 12/12/2018. (km) |
| Dec 7, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. PAR PHARMACEUTICAL, INC. served on 12/6/2018, answer due 12/27/2018. (LOWER, J.) |
| Dec 7, 2018 | 9 | Notice of Voluntary Dismissal (aty) (6) Docket Text: NOTICE of Voluntary Dismissal by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENI, WILLIAM) |
| Dec 5, 2018 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Sep 11, 2018 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jem) |
| Sep 11, 2018 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jem) |
| Sep 11, 2018 | 6 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to PAR PHARMACEUTICAL, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jem) |
| Sep 10, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jjc, ) |
| Sep 9, 2018 | 1 | Complaint (24) |
| Sep 9, 2018 | 1 | Exhibit A (15) |
| Sep 9, 2018 | 1 | Exhibit B (16) |
| Sep 9, 2018 | 1 | Exhibit C (17) |
| Sep 9, 2018 | 1 | Exhibit D (17) |
| Sep 9, 2018 | 1 | Exhibit E (11) |
| Sep 9, 2018 | 1 | Exhibit F (14) |
| Sep 9, 2018 | 1 | Exhibit G (17) |
| Sep 9, 2018 | 1 | Exhibit H (11) |
| Sep 9, 2018 | 1 | Civil Cover Sheet (1) |
| Sep 9, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 9, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 9, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
| Sep 9, 2018 | 1 | Main Document (24) Docket Text: COMPLAINT against PAR PHARMACEUTICAL, INC. ( Filing and Admin fee $ 400 receipt number 0312-9009527), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 9, 2018 | 1 | Complaint* (1) |
